Guru Ownership Trend
Guru Analysis for Rhythm Pharmaceuticals, Inc. (RYTM)
Rhythm Pharmaceuticals, Inc. (RYTM), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $72.96 M.
Top institutional holders include Steven Cohen and Renaissance Technologies (RenTech).
Institutional sentiment is currently Bullish. This is evidenced by a $22.94 M net inflow during the quarter.
Recent activity highlights Steven Cohen who opened a new position. Conversely, Renaissance Technologies (RenTech) reduced exposure by 37.6%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Rhythm Pharmaceuticals, Inc. (RYTM)
Major holders include Steven Cohen ($45.97 M), Renaissance Technologies (RenTech) ($36.52 M), Cliff Asness ($7.5 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 845,510 shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $22.94 M, with 1 managers increasing positions and 3 managers reducing holdings.
During the most recent reporting period, 3 managers trimmed their positions, while 0 fully exited RYTM. The total reported sell value was $23.03 M.
Yes, 1 managers opened new positions in RYTM, and 0 increased their existing holdings. The total reported buy value was $45.97 M.